focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADAM.L Regulatory News (ADAM)

  • There is currently no data for ADAM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Dividend Distribution by Greater China Credit Fund

1 Apr 2014 07:00

RNS Number : 6597D
Adamas Finance Asia Limited
01 April 2014
 



Adamas Finance Asia Limited

 

("AFA" or the "Company")

 

Dividend Distribution by Greater China Credit Fund

 

Adamas Finance Asia Limited (AIM ticker: ADAM) is pleased to announce it has received its first dividend distribution in the amount of US$75,300 from its investment in August 2013 of US$1 million into the Greater China Credit Fund (the "Fund" or the "GCCF").

 

GCCF is an investment vehicle established by Hong Kong-based Adamas Asset Management (HK) Limited ("Adamas"), which in February 2014 became the investment manager to AFA following a reverse takeover.

 

Adamas established the Fund last year to target high-return investments by providing growth capital for small and medium sized enterprises (SMEs) predominantly in Greater China, whose requirements are currently under-served by the traditional banking sector.

 

The dividend is the first distribution made by GCCF. It reflects the strategic approach followed by the Adamas investment team, which places strong emphasis on a rigorous due diligence process, a requirement for robust collateral, and hands-on involvement, while targeting superior returns.  

 

AFA Chairman John Croft said: "We are delighted by this initial distribution which we believe provides a good example of how we are now positioned to generate strong returns for our shareholders following our restructuring, backed by the Adamas investment team."

 

Last year's launch by Adamas of GCCF followed successes achieved with an earlier Adamas fund established in March 2010, the Asia Private Credit Fund ("APCF"). Approximately 90% of invested deals have been exited, yielding a projected gross IRR of 28%.

The APCF was last year named winner of the prestigious Acquisition International Magazine (in collaboration with Preqin) "2013 Best Asia Mezzanine Fund of the Year Award".

Adamas was also earlier this month named as "highly commended" runner-up for the Private Debt Investor "Asia Lender of the Year Award 2013". According to Private Debt Investor, Adamas was "just pipped" into second place by the global giant KKR Asset Management "in one of the most closely fought categories".

 

Background on the GCCF

The GCCF targets investment in high growth SMEs predominantly in Greater China. The Fund focuses on providing secured financing to operationally strong growth companies, using a mix of debt, convertible instruments and structured or preferred equity to minimise investment risk. The Fund targets SMEs with an enterprise value of under US$400 million and EBITDA of less than US$40 million.

 

 

Enquiries:

 

John Croft

Adamas Finance Asia Limited

 

+44 (0) 7785 315 588

Tim Feather

W H Ireland Limited

 

+44 (0) 113 394 6600

Allan Piper

First City Public Relations (Hong Kong)

 

+852 2854 2666

Simon Hudson

First City Public Relations (London

+44 (0) 20 7920 3170

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEAXDFDDALEFF
Date   Source Headline
24th Oct 201810:24 amRNSNet Asset Value Update
16th Oct 201810:34 amRNSDirector/PDMR Shareholding
13th Sep 20187:00 amRNSInterim Results for Six Months Ended 30 June 2018
17th Aug 201811:43 amRNSResult of AGM
13th Aug 201810:50 amRNSNet Asset Value Update
26th Jul 201812:06 pmRNSNet Asset Value Update
23rd Jul 20189:44 amRNSDisposal of Interest in Global Pharm
11th Jul 201810:38 amRNSResult of General Meeting
28th Jun 20183:50 pmRNSPosting of Annual Report and Accounts
21st Jun 20187:00 amRNSFinal Results for the Year Ended 31 December 2017
21st Jun 20187:00 amRNSAppointment of Broker
15th Jun 20188:36 amRNSDisposal of Interest in Global Pharm & GM Notice
27th Apr 20187:00 amRNSUpdate on Disposal of Interest in Global Pharm
26th Apr 20181:57 pmRNSResult of General Meeting
20th Apr 20188:49 amRNSDirector/PDMR Shareholding
5th Apr 20183:54 pmRNSDisposal and Notice of General Meeting
29th Mar 20187:00 amRNSUpdate on Disposal of Interest in Global Pharm
26th Mar 20184:44 pmRNSIncreased Ownership in HKMH
19th Mar 20187:00 amRNSNew Investment
8th Feb 201812:17 pmRNSUpdate - Net Asset Value
2nd Feb 20188:24 amRNSDirector/PDMR Shareholding
15th Jan 20187:00 amRNSFurther re. Disposal of Interest in Global Pharm
21st Dec 20178:54 amRNSIncrease in Shareholding in Hong Kong Mining
31st Oct 201710:23 amRNSNet Asset Value Update
2nd Oct 20177:00 amRNSAppointment of Director
22nd Sep 20177:00 amRNSInterim Results For Six Months End 30 June 2017
20th Sep 201711:18 amRNSAGM and Share Consolidation
15th Sep 20177:00 amRNSDisposal of Interest in Global Pharm
30th Aug 20174:50 pmRNSProposed Share Consolidation
4th Aug 20173:36 pmRNSUpdate on Global Pharm Convertible Bond
27th Jul 20177:00 amRNSNet Asset Value(s)
20th Jul 20179:43 amRNSDirectorate Change
20th Jul 20179:27 amRNSAnnual General Meeting
3rd Jul 20179:14 amRNSAppointment of Director
29th Jun 201710:45 amRNSFinal Results
22nd Jun 20178:46 amRNSFurther Payment of Proceeds for TTS Disposal
15th Jun 20179:43 amRNSPayment of Proceeds for TTS Project Disposal
25th May 201711:06 amRNSResult of Meeting
2nd May 20177:00 amRNSChange of Investment Manager and Investing Policy
24th Feb 201711:45 amRNSUPDATE ON TTS PROJECT DISPOSAL
8th Feb 20179:26 amRNSUPDATE ON TTS PROJECT DISPOSAL
31st Jan 20177:00 amRNSDistribution from GCCF
23rd Jan 20179:15 amRNSUPDATE: REDEMPTION OF GLOBAL PHARM CONVERTIBLE
13th Jan 20178:15 amRNSUPDATE ON TTS PROJECT DISPOSAL
4th Jan 20179:00 amRNSProposed Disposal
29th Dec 20167:00 amRNSDirector/PDMR Shareholding
22nd Dec 20161:18 pmRNSDirector/PDMR Shareholding
20th Dec 20164:19 pmRNSDirector/PDMR Shareholding
13th Dec 20169:23 amRNSDirector/PDMR Shareholding
6th Dec 201612:34 pmRNSCorrection to Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.